Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Trial Status: active

This phase II trial tests tovorafenib for the treatment of craniopharyngioma that is newly diagnosed or has recurred (come back) in children or young adults who have undergone surgery or scheduled to have surgery as part of the normal treatment. Tovorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Tovorafenib prior to and following surgical resection of tumor cells, may help to effectively treat patients with craniopharyngioma while maintaining quality of life.